Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.
Prolonged effects of short-term anti-CD20 B cell depletion therapy in murine systemic lupus erythematosus.
复制标题
DOI:
10.1002/art.27515
复制
发表时间:
2010-08
影响因子:
--
通讯作者:
Anolik, Jennifer H.
中科院分区:
文献类型:
--
作者:
Bekar, Kai W.;Owen, Teresa;Dunn, Robert;Ichikawa, Travis;Wang, Wensheng;Wang, Roger;Barnard, Jennifer;Brady, Sean;Nevarez, Sarah;Goldman, Bruce I.;Kehry, Marilyn;Anolik, Jennifer H.
Although B cells are implicated in the pathogenesis of systemic lupus erythematosus (SLE), the role of B cell depletion (BCD) as a treatment is controversial given the variable benefit in human disease. The development of a murine lupus model of BCD would be helpful to better understand mechanisms, heterogeneity, and effects on disease outcomes. NZB/NZWF1 female mice of varying disease severity received anti-CD20 antibody (IgG2a), BR3-Fc, or control antibody (10 mg/kg). Tissues were harvested and analyzed by flow cytometry. Nephritis was monitored by proteinuria (Uristix) and kidney IHC. Serum immunoglobulin levels were measured by ELISA. After a single injection of anti-mCD20 B cell depletion was more efficient in peripheral blood, lymph node, and spleen compared to the bone marrow and peritoneum in normal mice as well as in young and diseased lupus mice. Since depletion of the marginal zone and peritoneal B cells was incomplete and variable particularly in older mice with established nephritis, a sequential weekly dosing strategy was subsequently used with improved depletion. BAFF blockade further enhanced depletion in spleen and lymph node. Early BCDT delayed disease onset, whereas BCDT in mice with advanced disease reduced the progression of nephritis. These effects were long-lasting even after B cell reconstitution occurred and associated with a reduction in T cell activation but no significant change in autoantibody production. The lasting benefit of a short course of BCD in lupus prone mice with an intact immune system and established disease highlights the validity of this treatment approach.
登录
查看更多内容
影响因子:
--
作者:
Leandro, MJ;Edwards, JC;Isenberg, DA
通讯作者:
Isenberg, DA
DOI:
10.4049/jimmunol.0803052
发表时间:
2009-03-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Blair PA;Chavez-Rueda KA;Evans JG;Shlomchik MJ;Eddaoudi A;Isenberg DA;Ehrenstein MR;Mauri C
通讯作者:
Mauri C
影响因子:
--
作者:
Looney, RJ;Anolik, JH;Sanz, I
通讯作者:
Sanz, I
影响因子:
4.4
作者:
Hamaguchi, Y;Uchida, J;Tedder, TF
通讯作者:
Tedder, TF
影响因子:
15.9
作者:
Hu, Chang-Yun;Rodriguez-Pinto, Daniel;Wen, Li
通讯作者:
Wen, Li